Atesci, F

Bostanci, M

Ergin, A

Ergin, N

Karadag, F

Oguzhanoglu, NK

Ozdel, L

Ozdel, O

Croatian Medical Journal

Aim To determine overall and subgroup prevalence of depressive symptomatology among university students in Denizli, Turkey during the 1999-2000 academic year, and to investigate whether sociodemographic factors were associated with depressive symptoms in university students.Methods A stratified probability sample of 504 Turkish university students (296 male, 208 female) was used in a cross-sectional study. Data were obtained by self-administered questionnaire, including questions on sociodemographic characteristics and problem areas. The revised Beck Depression Inventory (BDI) was used to determine depressive symptoms of the participants. BDI scores 17 or higher were categorized as depressive for logistic regression analysis. Student Rest and linear regression were used for continuous data analysis.Results Out of all participants, 26.2% had a BDI score 17 or higher. The prevalence of depressive symptoms increased to 32.1% among older students, 34.7% among students with low socioeconomic status, 31.2% among seniors, and 62.9% among students with poor school performance. The odds ratio of depressive symptoms was 1.84 (95% confidence interval [CI], 1.03-3.28) in students with low socioeconomic status and 7.34 (95% CI, 3.36-16.1) in students with poor school performance in the multivariate logistic model. The participants identified several problem areas: lack of social activities and shortage of facilities on the campus (69.0%), poor quality of the educational system (54.8%), economic problems (49.3%), disappointment with the university (43.2%), and friendship problems (25.9%).Conclusions Considering the high frequency of depressive symptoms among Turkish university students, a student counseling service offering mental health assistance is necessary. This service should especially find the way to reach out to poor students and students with poor school performance

Pamukkale Üniversitesi Açık Erişim Arşivi

Prevalence and sociodemographic correlates

CDC Stacks

 Update on HPV Vaccination  Coverage in the US     Shannon Stokley, MPH National Center for Immunization and Respiratory Diseases  Advisory Committee on Immunization Practices October 24, 2013    National Center for Immunization and Respiratory Diseases Immunization Services Division US HPV Vaccination Program  HPV is one of several vaccines recommended for the adolescent age group  Majority of vaccines are administered in primary care provider offices and publicly funded clinics  National survey of physicians found that 98% of pediatricians and 88% of family physicians stocked and administered HPV vaccine*  Vaccine covered by most private health insurance companies and government insurance programs  In 2011, 39.4% of adolescents 13-17 years of age were eligible for VFC vaccine    *Daley et al. Pediatrics. 2010;126:425-433.  National Immunization Survey-Teen (NIS-Teen)  Annual survey  Implemented in 2006  State level estimates available beginning 2008  Uses National Immunization Survey (NIS) sample frame methodology  Random digit dial telephone survey  National sample of parents of adolescents aged 13-17 years  Starting 2011, uses a dual sample frame (landline and cell phone)  Provider record check for verification of immunizations received  All analyses limited to adolescents with provider reported immunization histories   National Estimated Vaccination Coverage Levels among Adolescents 13-17 Years,   NIS-Teen 2006-2012 0204060801002006 2007 2008 2009 2010 2011 2012Percent Year Tdap MCV4 >1 HPV (girls) 3 HPV (girls) >1 HPV (boys) 3 HPV (boys) Source: MMWR. 2013;62;685-93 ≤ 44% (8) 45-54% (19) 55-64% (17) ≥65% (6) Coverage of 1 of More Doses of HPV among Adolescent Girls 13-17 Years by State, NIS-Teen 2012 Alabama Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming Alaska Hawaii Alaska Source: MMWR. 2013;62;685-93 Vaccination Estimates among Adolescents 13-17 Years by Poverty Status, NIS-Teen 2012 65 36 30 11 50 33 17 6 0204060801001 HPV 3 HPV 1 HPV 3 HPVBelow Poverty At or Above Poverty** statistically different (p<0.05) Source: MMWR. 2013;62;685-93 ** ** ** Girls Boys HPV Vaccination Estimates among Adolescent 13-17 Years  by Race/Ethnicity, NIS-Teen 2012 51 34 15 5 50 29 26 5 63 36 32 13 0204060801001 HPV 3 HPV 1 HPV 3 HPVPercent White-NH Black-NH Hispanic** Statistically different (P<0.05) from White-NH. Source: MMWR. 2013;62;685-93 ** ** ** ** Girls Boys Completion of the HPV series 72 64 59 020406080100White-NH Black-NH Hispanic Completion: among the girls that started the series, the proportion that received all 3 doses  Nationally, 67% of girls that start the HPV series, complete the series  ** Statistically different (P<0.05) from White-NH. Source: MMWR. 2013;62;685-93 ** ** HPV Vaccine Intentions (in the Next 12 Months) Among Parents of Adolescent Girls 13-17 Years, NIS-Teen 37 44 49 53 54 28 21 17 17 17 26 27 28 25 23 9 8 7 5 7 0%20%40%60%80%100%2008 2009 2010 2011 2012Unsure/unknownNot likelySomewhat/very likelyVaccinatedTop 5 reasons for not vaccinating daughter, among parents with no intention to vaccinate in the next 12 months, NIS-Teen 2012 Not needed or necessary 19.1% Not recommended by provider 14.2% Safety concern/side effects 13.3% Lack of knowledge 12.6% Not sexually active 10.1% MMWR. 2013; 62:591-5 Current Strength of Recommendation  in Females, Pediatricians and Family Physicians (N=609)* 87 82 53 10 15 37 2 3 8 1 2 0% 20% 40% 60% 80% 100%16-18 yo females13-15 yo females11-12 yo femalesStrongly recommend Recommend, but not stronglyMake no recommendation Recommend againstAllison et al.  Academic Pediatrics. 2013;13:466-74. HPV Vaccine Communications During the Healthcare Encounter  HPV vaccine is often presented as ‘optional’ whereas other adolescent vaccines are recommended  Some expressed mixed or negative opinions about the ‘new vaccine’ and concerns over safety/efficacy  When parents expressed reluctance, providers were hesitant to engage in discussion  Some providers shared parents’ views that teen was not at risk for HPV and could delay vaccination until older Goff S et al. Vaccine 2011;10:7343-9  Hughes C et al. BMC Pediatrics 2011;11:74 Actual and potentially achievable vaccination coverage of >1 HPV among adolescent girls if missed opportunities* were eliminated, NIS-Teen 25.1 37.2 44.3 48.7 53.0 53.8 40.6 56.5 73.5 83.5 89.5 92.6 0204060801002007 2008 2009 2010 2011 2012*Missed opportunity defined as having a healthcare encounter where at least one vaccine was administered but HPV was not MMWR. 2013; 62:591-5 Actual Potential Among unvaccinated girls,  84% had a missed opportunity for HPV Summary  Progress with improving HPV vaccination coverage among U.S. adolescent girls has stalled  Vaccination coverage among boys is increasing  Main reasons parents give for not vaccinating daughters indicate lack of awareness/gaps in understanding need for vaccination  Primary care providers are key to increasing vaccination coverage  Provide strong recommendations   Do not delay vaccination  Implement evidence-based strategies to improve vaccine delivery  Prevent missed vaccination opportunities  CDC Activities  Awarded PPHF funds to11 immunization awardees to conduct targeted activities to increase HPV coverage  Initiating study to improve physicians’ communication skills and comfort level with talking about and recommending HPV vaccines  Research-based outreach and education to parents to improve awareness and vaccine uptake Additional CDC Communication Activities  Developed TIPS sheet for clinicians (http://www.cdc.gov/vaccines/who/teens/for-hcp-tipsheet-hpv.html)   Created speakers bureau of HPV-related cancer specialists to present to pediatricians and family physicians on the importance of HPV vaccination  Media outreach through professional and parent channels   HPV Vaccination Resources for HCPs www.cdc.gov/vaccines/YouAreTheKey Acknowledgements  Robin Curtis  Jenny Jeyarajah  David Yankey  Janine Cory  Jill Roark  Lauri Markowitz Thank you zma2@cdc.gov For more information please contact Centers for Disease Control and Prevention  1600 Clifton Road NE, Atlanta,  GA  30333 Telephone:  1-800-CDC-INFO (232-4636)/TTY: 1-888-232-6348 E-mail:  cdcinfo@cdc.gov  Web:  http://www.cdc.gov  The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. National Center for Immunization and Respiratory Diseases  Immunization Services Division 

English

Update on HPV vaccination coverage in the US

Update on HPV vaccination coverage in the US

Abstract

Similar works

Full text

Available Versions

Pamukkale Üniversitesi Açık Erişim Arşivi

CDC Stacks